Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
April-2021 Volume 21 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2021 Volume 21 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis

  • Authors:
    • Kalliopi Mavrea
    • Vasiliki Efthymiou
    • Katerina Katsibardi
    • Konstantinos Tsarouhas
    • Christina Kanaka‑Gantenbein
    • Demetrios A. Spandidos
    • George Chrousos
    • Antonis Kattamis
    • Flora Bacopoulou
  • View Affiliations / Copyright

    Affiliations: Clinic for Assessment of Adolescent Learning Difficulties, Center for Adolescent Medicine and UNESCO Chair on Adolescent Health Care, First Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens 11527, Greece, University Research Institute of Maternal and Child Health and Precision Medicine, and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens 11527, Greece, Pediatric Hematology‑Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens 11527, Greece, Department of Cardiology, University Hospital of Larissa, Larissa 41110, Greece, Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion 71409, Greece
    Copyright: © Mavrea et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 262
    |
    Published online on: February 5, 2021
       https://doi.org/10.3892/ol.2021.12523
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Pediatric cancer and its treatment may have an impact on the neurocognitive functions of childhood cancer survivors (CCS). The aim of the present meta‑analysis was to compare the intelligence quotient (IQ) scores between CCS of acute lymphoblastic leukemia (ALL) and controls. A comprehensive electronic search identified original research articles that reported scores of the Wechsler Intelligence Scale (WISC; WISC‑III, WISC‑IV and WISC‑R) for children and adolescents, aged 6‑16 years at evaluation, survivors of ALL and healthy controls. The included CCS had completed anticancer treatment and were in remission at the time of assessment. A total of 16 studies were included in the meta‑analysis, out of 128 extracted studies, and involved a total of 1,676 children and adolescents: 991 CCS (ALL) and 685 healthy controls. Among the studies, a random effects model revealed a moderate estimate of effect size [standardized mean difference (SMD), ‑0.78; 95% CI, ‑1.05 to ‑0.50], indicating that the WISC scores for total IQ were significantly lower in the CCS than in the controls. The mean total IQ range was 85.2‑107.2 in the CCS and 88.4‑114.1 in the controls. The difference in the mean total IQ between controls and CCS ranged from ‑13.8 to 20.6. As regards the WISC scores for verbal IQ, 11 studies were included. A random effects model revealed a moderate estimate of effect size (SMD, ‑0.71; 95% CI, ‑1.05 to ‑0.38), indicating that the WISC scores for verbal IQ were significantly lower in the CCS than in the controls. Among the 9 studies that had available data for performance IQ scores, a fixed effect model revealed a moderate estimate of effect size (SMD, ‑0.80; 95% CI, ‑1.09 to ‑0.52), indicating that the WISC scores for performance IQ were significantly lower in the CCS than in the controls. As the survival rates of children and adolescents with ALL are steadily increasing, regular, lifelong follow‑up for neurocognitive late effects is imperative in order to improve their education and employment prospects and overall, their quality of life.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, et al: SEER Cancer Statistics Review, 1975–2010. National Cancer Institute; Bethesda, MD: 2013

2 

Hunger SP and Mullighan CG: Acute lymphoblastic leukemia in children. N Engl J Med. 373:1541–1552. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Van Dongen-Melman JE: Developing psychosocial aftercare for children surviving cancer and their families. Acta Oncol. 39:23–31. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Mohrmann C, Henry J, Hauff M and Hayashi RJ: Neurocognitive outcomes and school performance in solid tumor cancer survivors lacking therapy to the central nervous system. J Pers Med. 5:83–90. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Askins MA and Moore BD III: Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol. 23:1160–1171. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Bhatia S and Constine LS: Late morbidity after successful treatment of children with cancer. Cancer J. 15:174–180. 2009. View Article : Google Scholar : PubMed/NCBI

7 

de Ruiter MA, Schouten-Van Meeteren AYN, van Mourik R, Janssen TWP, Greidanus JEM, Oosterlaan J and Grootenhuis MA: Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: Design of a randomized controlled double-blind trial. BMC Cancer. 12:581–589. 2012. View Article : Google Scholar : PubMed/NCBI

8 

De Houwer J, Barnes-Holmes D and Moors A: What is learning? On the nature and merits of a functional definition of learning. Psychon Bull Rev. 20:631–642. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Çeliköz N, Erişen Y and Şahin M: Cognitive learning theories. Learning and Teaching: Theories, Approaches and Models. Akdemir AS, Kaya Z and Akdemir OA: 1st English Edition. Çözüm Publishing; Ankara: 2016

10 

Wenger BL, Kaye HS and La Plante MP: Disabilities Among Children. Disability Statistics Abstract. No. 15. U.S. Department of Education, National Institute on Disability and Rehabilitation Research; Washington, DC: 1995

11 

Institute of Medicine (US) and National Research Council (US) National Cancer Policy Board, ; Hewitt M, Weiner SL and Simone JV: Childhood Cancer Survivorship: Improving Care and Quality of Life. National Academies Press; Washington, DC: 2003

12 

Bisen-Hersh EB, Hineline PN and Walker EA: Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models. J Cancer. 2:292–301. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Haupt R, Fears TR, Robison LL, Mills JL, Nicholson HS, Zeltzer LK, Meadows AT and Byrne J: Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA. 272:1427–1432. 1994. View Article : Google Scholar : PubMed/NCBI

14 

Vardy J, Wefel JS, Ahles T, Tannock IF and Schagen SB: Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Ann Oncol. 19:623–629. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Brown RT, Sawyer MB, Antoniou G, Toogood I, Rice M, Thompson N and Madan-Swain A: A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia. J Dev Behav Pediatr. 17:392–398. 1996. View Article : Google Scholar : PubMed/NCBI

16 

Zhou C, Zhuang Y, Lin X, Michelson AD and Zhang A: Changes in neurocognitive function and central nervous system structure in childhood acute lymphoblastic leukaemia survivors after treatment: A meta-analysis. Br J Haematol. 188:945–961. 2020. View Article : Google Scholar : PubMed/NCBI

17 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J and Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 6:e10001002009. View Article : Google Scholar : PubMed/NCBI

18 

Said JA, Waters BGH, Cousens P and Stevens MM: Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia. J Consult Clin Psychol. 57:251–256. 1989. View Article : Google Scholar : PubMed/NCBI

19 

Cetingül N, Aydinok Y, Kantar M, Oniz H, Kavakli K, Yalman O, Erermiş S, Celebisoy N, Akyürekli O, Oztop S, et al: Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 16:213–220. 1999. View Article : Google Scholar : PubMed/NCBI

20 

Raymond-Speden E, Tripp G, Lawrence B and Holdaway D: Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. J Pediatr Psychol. 25:59–68. 2000. View Article : Google Scholar : PubMed/NCBI

21 

Anderson VA, Godber T, Smibert E, Weiskop S and Ekert H: Cognitive and academic outcome following cranial irradiation and chemotherapy in children: A longitudinal study. Br J Cancer. 82:255–262. 2000. View Article : Google Scholar : PubMed/NCBI

22 

Reinfjell T, Lofstad GE, Veenstra M, Vikan A and Diseth TH: Health-related quality of life and intellectual functioning in children in remission from acute lymphoblastic leukaemia. Acta Paediatr. 96:1280–1285. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Lofstad GE, Reinfjell T, Hestad K and Diseth TH: Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only. Acta Paediatr. 98:180–186. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Carey ME, Haut MW, Reminger SL, Hutter JJ, Theilmann R and Kaemingk KL: Reduced frontal white matter volume in long-term childhood leukemia survivors: A voxel-based morphometry study. AJNR Am J Neuroradiol. 29:792–797. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Aukema EJ, Caan MWA, Oudhuis N, Majoie CBLM, Vos FM, Reneman L, Last BF, Grootenhuis MA and Schouten-van Meeteren AYN: White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys. 74:837–843. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Halsey C, Buck G, Richards S, Vargha-Khadem F, Hill F and Gibson B: The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. J Hematol Oncol. 4:422011. View Article : Google Scholar : PubMed/NCBI

27 

Zou P, Li Y, Conklin HM, Mulhern RK, Butler RW and Ogg RJ: Evidence of change in brain activity among childhood cancer survivors participating in a cognitive remediation program. Arch Clin Neuropsychol. 27:915–929. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Kesler SR, Gugel M, Pritchard-Berman M, Lee C, Kutner E, Hosseini SM, Dahl G and Lacayo N: Altered resting state functional connectivity in young survivors of acute lymphoblastic leukemia. Pediatr Blood Cancer. 61:1295–1299. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Reddick WE, Taghipour DJ, Glass JO, Ashford J, Xiong X, Wu S, Bonner M, Khan RB and Conklin HM: Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers. Pediatr Blood Cancer. 61:1074–1079. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Kim SJ, Park MH, Lee JW, Chung NG, Cho B, Lee IG and Chung SY: Neurocognitive outcome in survivors of childhood acute lymphoblastic leukemia: Experience at a tertiary care hospital in Korea. J Korean Med Sci. 30:463–469. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Van Der Plas E, Erdman L, Nieman BJ, Weksberg R, Butcher DT, O'connor DL, Aufreiter S, Hitzler J, Guger SL, Schachar RJ, et al: Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures. Child Neuropsychol. 24:999–1014. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Darling S, De Luca CR, Anderson V, McCarthy M, Hearps S and Seal M: Brain morphology and information processing at the completion of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Dev Neurorehabil. 22:293–302. 2019. View Article : Google Scholar : PubMed/NCBI

33 

Sherief LM, Sanad R, ElHaddad A, Shebl A, Abdelkhalek ER, Elsafy ER, Hassan TH, Raafat N, Kamal NM and Attia EI: A cross-sectional study of two chemotherapy protocols on long term neurocognitive functions in Egyptian children surviving acute lymphoblastic leukemia. Curr Pediatr Rev. 14:253–260. 2018. View Article : Google Scholar : PubMed/NCBI

34 

Malard F and Mohty M: Acute lymphoblastic leukaemia. Lancet. 395:1146–1162. 2020. View Article : Google Scholar : PubMed/NCBI

35 

Rey-Casserly C and Meadows ME: Developmental perspectives on optimizing educational and vocational outcomes in child and adult survivors of cancer. Dev Disabil Res Rev. 14:243–250. 2008. View Article : Google Scholar : PubMed/NCBI

36 

Caron JE, Krull KR, Hockenberry M, Jain N, Kaemingk K and Moore IM: Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer. 53:551–556. 2009. View Article : Google Scholar : PubMed/NCBI

37 

Cole PD, Beckwith KA, Vijayanathan V, Roychowdhury S, Smith AK and Kamen BA: Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia. Pediatr Neurol. 40:34–41. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Ikonomidou C: Chemotherapy and the pediatric brain. Mol Cell Pediatr. 5:82018. View Article : Google Scholar : PubMed/NCBI

39 

Pääkkö E, Harila-Saari A, Vanionpää L, Himanen S, Pyhtinen J and Lanning M: White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: Correlation with neuropsychological findings. Med Pediatr Oncol. 35:456–461. 2000. View Article : Google Scholar : PubMed/NCBI

40 

Cole PD, Finkelstein Y, Stevenson KE, Blonquist TM, Vijayanathan V, Silverman LB, Neuberg DS, Sallan SE, Robaey P and Waber DP: Polymorphisms in genes related to oxidative stress are associated with inferior cognitive function after therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 33:2205–2211. 2015. View Article : Google Scholar : PubMed/NCBI

41 

van der Plas E, Schachar RJ, Hitzler J, Crosbie J, Guger SL, Spiegler BJ, Ito S and Nieman BJ: Brain structure, working memory and response inhibition in childhood leukemia survivors. Brain Behav. 7:e006212016. View Article : Google Scholar : PubMed/NCBI

42 

Cruz-Sanchez FF, Artigas J, Cervos-Navarro J, Rossi ML and Ferszt R: Brain lesions following combined treatment with methotrexate and craniospinal irradiation. J Neurooncol. 10:165–171. 1991. View Article : Google Scholar : PubMed/NCBI

43 

Antunes NL, Souweidane MM, Lis E, Rosenblum MK and Steinherz PG: Methotrexate leukoencephalopathy presenting as Klüver-Bucy syndrome and uncinate seizures. Pediatr Neurol. 26:305–308. 2002. View Article : Google Scholar : PubMed/NCBI

44 

DeAngelis LM, Seiferheld W, Schold SC, Fisher B and Schultz CJ; Radiation Therapy Oncology Group Study 93-10, : Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol. 20:4643–4648. 2002. View Article : Google Scholar : PubMed/NCBI

45 

Lai R, Abrey LE, Rosenblum MK and DeAngelis LM: Treatment-induced leukoencephalopathy in primary CNS lymphoma: A clinical and autopsy study. Neurology. 62:451–456. 2004. View Article : Google Scholar : PubMed/NCBI

46 

Rubinstein LJ, Herman MM, Long TF and Wilbur JR: Disseminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma. Cancer. 35:291–305. 1975. View Article : Google Scholar : PubMed/NCBI

47 

Stone JA, Castillo M and Mukherji SK: Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy. Neuroradiology. 41:134–136. 1999. View Article : Google Scholar : PubMed/NCBI

48 

Abelson HT: Methotrexate and central nervous system toxicity. Cancer Treat Rep. 62:1999–2001. 1978.PubMed/NCBI

49 

Allen JC, Rosen G, Mehta BM and Horten B: Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep. 64:1261–1273. 1980.PubMed/NCBI

50 

Omuro AM, DeAngelis LM, Yahalom J and Abrey LE, DeAngelis LM, Yahalom J and Abrey LE: Chemoradiotherapy for primary CNS lymphoma: An intent-to-treat analysis with complete follow-up. Neurology. 64:69–74. 2005. View Article : Google Scholar : PubMed/NCBI

51 

Lövblad K, Kelkar P, Ozdoba C, Ramelli G, Remonda L and Schroth G: Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Pediatr Radiol. 28:86–91. 1998. View Article : Google Scholar : PubMed/NCBI

52 

Sleurs C, Lemiere J, Vercruysse T, Nolf N, Van Calster B, Deprez S, Renard M, Vandecruys E, Benoit Y and Uyttebroeck A: Intellectual development of childhood ALL patients: A multicenter longitudinal study. Psychooncology. 26:508–514. 2017. View Article : Google Scholar : PubMed/NCBI

53 

Perry A and Schmidt RE: Cancer therapy-associated CNS neuropathology: An update and review of the literature. Acta Neuropathol. 111:197–212. 2006. View Article : Google Scholar : PubMed/NCBI

54 

Krull KR, Brinkman TM, Li C, Armstrong GT, Ness KK, Srivastava DK, Gurney JG, Kimberg C, Krasin MJ, Pui CH, et al: Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: A report from the St Jude lifetime cohort study. J Clin Oncol. 31:4407–4415. 2013. View Article : Google Scholar : PubMed/NCBI

55 

Barrera M, Shaw AK, Speechley KN, Maunsell E and Pogany L: Educational and social late effects of childhood cancer and related clinical, personal, and familial characteristics. Cancer. 104:1751–1760. 2005. View Article : Google Scholar : PubMed/NCBI

56 

Dumas A, Berger C, Auquier P, Michel G, Fresneau B, Allodji RS, Haddy N, Rubino C, Vassal G, Valteau-Couanet D, et al: Educational and occupational outcomes of childhood cancer survivors 30 years after diagnosis: A French cohort study. Br J Cancer. 114:1060–1068. 2016. View Article : Google Scholar : PubMed/NCBI

57 

Sohlberg M and Mateer C: Attention Process Training (APT). Association for Neuropsychological Research and Development; Washington, DC: 1987, PubMed/NCBI

58 

Thomson J and Kerns K: Pay Attention! A children's attention process training program. 2nd edition. Lash & Associates Publishing; Wake Forest, NC: 2005

59 

Penkman L: Remediation of attention deficits in children: A focus on childhood cancer, traumatic brain injury and attention deficit disorder. Pediatr Rehabil. 7:111–123. 2004. View Article : Google Scholar : PubMed/NCBI

60 

Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlström K, Gillberg CG, Forssberg H and Westerberg H: Computerized training of working memory in children with ADHD - a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 44:177–186. 2005. View Article : Google Scholar : PubMed/NCBI

61 

Shaw EG, Rosdhal R, D'Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME and Rapp SR: Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol. 24:1415–1420. 2006. View Article : Google Scholar : PubMed/NCBI

62 

Klonoff-Cohen H, Navarro A and Klonoff EA: Late effects awareness website for pediatric survivors of acute lymphocytic leukemia. PLoS One. 13:e01931412018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Mavrea K, Efthymiou V, Katsibardi K, Tsarouhas K, Kanaka‑Gantenbein C, Spandidos DA, Chrousos G, Kattamis A and Bacopoulou F: Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis. Oncol Lett 21: 262, 2021.
APA
Mavrea, K., Efthymiou, V., Katsibardi, K., Tsarouhas, K., Kanaka‑Gantenbein, C., Spandidos, D.A. ... Bacopoulou, F. (2021). Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis. Oncology Letters, 21, 262. https://doi.org/10.3892/ol.2021.12523
MLA
Mavrea, K., Efthymiou, V., Katsibardi, K., Tsarouhas, K., Kanaka‑Gantenbein, C., Spandidos, D. A., Chrousos, G., Kattamis, A., Bacopoulou, F."Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis". Oncology Letters 21.4 (2021): 262.
Chicago
Mavrea, K., Efthymiou, V., Katsibardi, K., Tsarouhas, K., Kanaka‑Gantenbein, C., Spandidos, D. A., Chrousos, G., Kattamis, A., Bacopoulou, F."Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis". Oncology Letters 21, no. 4 (2021): 262. https://doi.org/10.3892/ol.2021.12523
Copy and paste a formatted citation
x
Spandidos Publications style
Mavrea K, Efthymiou V, Katsibardi K, Tsarouhas K, Kanaka‑Gantenbein C, Spandidos DA, Chrousos G, Kattamis A and Bacopoulou F: Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis. Oncol Lett 21: 262, 2021.
APA
Mavrea, K., Efthymiou, V., Katsibardi, K., Tsarouhas, K., Kanaka‑Gantenbein, C., Spandidos, D.A. ... Bacopoulou, F. (2021). Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis. Oncology Letters, 21, 262. https://doi.org/10.3892/ol.2021.12523
MLA
Mavrea, K., Efthymiou, V., Katsibardi, K., Tsarouhas, K., Kanaka‑Gantenbein, C., Spandidos, D. A., Chrousos, G., Kattamis, A., Bacopoulou, F."Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis". Oncology Letters 21.4 (2021): 262.
Chicago
Mavrea, K., Efthymiou, V., Katsibardi, K., Tsarouhas, K., Kanaka‑Gantenbein, C., Spandidos, D. A., Chrousos, G., Kattamis, A., Bacopoulou, F."Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta‑analysis". Oncology Letters 21, no. 4 (2021): 262. https://doi.org/10.3892/ol.2021.12523
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team